Cargando…
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy
The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of debate. We here describe the course and the outcome of COVID-19 in a cohort of patients undergoing treatment with calcineurin inhibitors. In this monocentric cohort study, data were collected from the COVID-19 outb...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409165/ https://www.ncbi.nlm.nih.gov/pubmed/32629788 http://dx.doi.org/10.3390/microorganisms8070977 |
_version_ | 1783568002499739648 |
---|---|
author | Cavagna, Lorenzo Seminari, Elena Zanframundo, Giovanni Gregorini, Marilena Di Matteo, Angela Rampino, Teresa Montecucco, Carlomaurizio Pelenghi, Stefano Cattadori, Barbara Pattonieri, Eleonora Francesca Vitulo, Patrizio Bertani, Alessandro Sambataro, Gianluca Vancheri, Carlo Biglia, Alessandro Bozzalla-Cassione, Emanuele Bonetto, Valentina Monti, Maria Cristina Ticozzelli, Elena Turco, Annalisa Oggionni, Tiberio Corsico, Angelo Bertuccio, Francesco Zuccaro, Valentina Codullo, Veronica Morosini, Monica Marena, Carlo Gnecchi, Massimiliano Pellegrini, Carlo Meloni, Federica |
author_facet | Cavagna, Lorenzo Seminari, Elena Zanframundo, Giovanni Gregorini, Marilena Di Matteo, Angela Rampino, Teresa Montecucco, Carlomaurizio Pelenghi, Stefano Cattadori, Barbara Pattonieri, Eleonora Francesca Vitulo, Patrizio Bertani, Alessandro Sambataro, Gianluca Vancheri, Carlo Biglia, Alessandro Bozzalla-Cassione, Emanuele Bonetto, Valentina Monti, Maria Cristina Ticozzelli, Elena Turco, Annalisa Oggionni, Tiberio Corsico, Angelo Bertuccio, Francesco Zuccaro, Valentina Codullo, Veronica Morosini, Monica Marena, Carlo Gnecchi, Massimiliano Pellegrini, Carlo Meloni, Federica |
author_sort | Cavagna, Lorenzo |
collection | PubMed |
description | The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of debate. We here describe the course and the outcome of COVID-19 in a cohort of patients undergoing treatment with calcineurin inhibitors. In this monocentric cohort study, data were collected from the COVID-19 outbreak in Italy up to 28 April 2020. Patients were followed at our hospital for solid organ transplantation or systemic rheumatic disorders (RMDs) and were on calcineurin inhibitor (CNI)-based therapy. Selected patients were referred from the North of Italy. The aim of our study was to evaluate the clinical course of COVID-19 in this setting. We evaluated 385 consecutive patients (220 males, 57%; median age 61 years, IQR 48–69); 331 (86%) received solid organ transplantation and 54 (14%) had a RMD. CNIs were the only immunosuppressant administered in 47 patients (12%). We identified 14 (4%) COVID-19 patients, all transplanted, mainly presenting with fever (86%) and diarrhea (71%). Twelve patients were hospitalized and two of them died, both with severe comorbidities. No patients developed acute respiratory distress syndrome or infectious complications. The surviving 10 patients are now fully recovered. The clinical course of COVID-19 patients on CNIs is generally mild, and the risk of superinfection seems low. |
format | Online Article Text |
id | pubmed-7409165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74091652020-08-26 Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy Cavagna, Lorenzo Seminari, Elena Zanframundo, Giovanni Gregorini, Marilena Di Matteo, Angela Rampino, Teresa Montecucco, Carlomaurizio Pelenghi, Stefano Cattadori, Barbara Pattonieri, Eleonora Francesca Vitulo, Patrizio Bertani, Alessandro Sambataro, Gianluca Vancheri, Carlo Biglia, Alessandro Bozzalla-Cassione, Emanuele Bonetto, Valentina Monti, Maria Cristina Ticozzelli, Elena Turco, Annalisa Oggionni, Tiberio Corsico, Angelo Bertuccio, Francesco Zuccaro, Valentina Codullo, Veronica Morosini, Monica Marena, Carlo Gnecchi, Massimiliano Pellegrini, Carlo Meloni, Federica Microorganisms Communication The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of debate. We here describe the course and the outcome of COVID-19 in a cohort of patients undergoing treatment with calcineurin inhibitors. In this monocentric cohort study, data were collected from the COVID-19 outbreak in Italy up to 28 April 2020. Patients were followed at our hospital for solid organ transplantation or systemic rheumatic disorders (RMDs) and were on calcineurin inhibitor (CNI)-based therapy. Selected patients were referred from the North of Italy. The aim of our study was to evaluate the clinical course of COVID-19 in this setting. We evaluated 385 consecutive patients (220 males, 57%; median age 61 years, IQR 48–69); 331 (86%) received solid organ transplantation and 54 (14%) had a RMD. CNIs were the only immunosuppressant administered in 47 patients (12%). We identified 14 (4%) COVID-19 patients, all transplanted, mainly presenting with fever (86%) and diarrhea (71%). Twelve patients were hospitalized and two of them died, both with severe comorbidities. No patients developed acute respiratory distress syndrome or infectious complications. The surviving 10 patients are now fully recovered. The clinical course of COVID-19 patients on CNIs is generally mild, and the risk of superinfection seems low. MDPI 2020-06-30 /pmc/articles/PMC7409165/ /pubmed/32629788 http://dx.doi.org/10.3390/microorganisms8070977 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Cavagna, Lorenzo Seminari, Elena Zanframundo, Giovanni Gregorini, Marilena Di Matteo, Angela Rampino, Teresa Montecucco, Carlomaurizio Pelenghi, Stefano Cattadori, Barbara Pattonieri, Eleonora Francesca Vitulo, Patrizio Bertani, Alessandro Sambataro, Gianluca Vancheri, Carlo Biglia, Alessandro Bozzalla-Cassione, Emanuele Bonetto, Valentina Monti, Maria Cristina Ticozzelli, Elena Turco, Annalisa Oggionni, Tiberio Corsico, Angelo Bertuccio, Francesco Zuccaro, Valentina Codullo, Veronica Morosini, Monica Marena, Carlo Gnecchi, Massimiliano Pellegrini, Carlo Meloni, Federica Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy |
title | Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy |
title_full | Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy |
title_fullStr | Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy |
title_full_unstemmed | Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy |
title_short | Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy |
title_sort | calcineurin inhibitor-based immunosuppression and covid-19: results from a multidisciplinary cohort of patients in northern italy |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409165/ https://www.ncbi.nlm.nih.gov/pubmed/32629788 http://dx.doi.org/10.3390/microorganisms8070977 |
work_keys_str_mv | AT cavagnalorenzo calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT seminarielena calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT zanframundogiovanni calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT gregorinimarilena calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT dimatteoangela calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT rampinoteresa calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT montecuccocarlomaurizio calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT pelenghistefano calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT cattadoribarbara calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT pattonierieleonorafrancesca calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT vitulopatrizio calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT bertanialessandro calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT sambatarogianluca calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT vanchericarlo calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT bigliaalessandro calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT bozzallacassioneemanuele calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT bonettovalentina calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT montimariacristina calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT ticozzellielena calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT turcoannalisa calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT oggionnitiberio calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT corsicoangelo calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT bertucciofrancesco calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT zuccarovalentina calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT codulloveronica calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT morosinimonica calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT marenacarlo calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT gnecchimassimiliano calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT pellegrinicarlo calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly AT melonifederica calcineurininhibitorbasedimmunosuppressionandcovid19resultsfromamultidisciplinarycohortofpatientsinnorthernitaly |